Ask AI
ProCE Banner Events

Share

APP Intensive: Dermatology

This virtual conference is a series of dynamic, case-based educational programs designed to enhance the expertise of nurse practitioners and physician associates in diagnosing and managing complex dermatologic conditions. It features in-depth sessions covering the latest evidence and clinical strategies for treatment, equipping learners with the tools to optimize patient care and improve outcomes.

Physician Assistants/Physician Associates: 4.00 AAPA Category 1 CME credits

Nurse Practitioners/Nurses: 4.00 Nursing contact hours, including 4.00 hours of pharmacotherapy credit

Who Should Attend

This activity is intended for dermatology nurse practitioners, physician associates and other advanced practice providers practicing in a dermatology setting.

Time and location

Saturday, August 01, 2026

10:00 AM - 5:00 PM Eastern Time (ET)

Virtual

Agenda

Detailed Agenda Coming Soon

Closing Practice Gaps in Systemic Mastocytosis: A Skills-Based Intensive for APPs
Presented By: TBD

  • This intensive program will focus on recognizing and evaluating systemic mastocytosis (SM) in dermatology practice, with an emphasis on distinguishing cutaneous manifestations from systemic disease. Through case based discussion and expert commentary, learners will explore key diagnostic red flags, appropriate use of laboratory testing and biopsy, and referral pathways for multidisciplinary management. The session will also address current and emerging treatment considerations, symptom burden, and strategies to improve coordination of care for patients with suspected or confirmed SM.

Think You Know JAK? Essential Evidence to Aid Your Clinical Implementation of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo
Presented By: TBD

  • This interactive program will examine persistent misconceptions and areas of uncertainty surrounding the use of Janus kinase (JAK) inhibitors in dermatology practice. Through expert commentary and clinical examples, learners will explore commonly held assumptions related to safety, patient selection, monitoring, and real world use of JAK inhibitors across inflammatory skin diseases. The session will focus on distinguishing evidence based facts from myths, interpreting emerging data, and supporting balanced, individualized risk–benefit discussions with patients as the dermatology treatment landscape continues to evolve.

CME/CE Info

Goal Statements

Closing Practice Gaps in Systemic Mastocytosis: A Skills-Based Intensive for APPs
The goal of this educational activity is to improve the knowledge and competence of NP and PA learners in leveraging evidence-based, patient-centered care strategies to improve disease control and quality of life for patients with SM.

Think You Know JAK? Essential Evidence to Aid Your Clinical Implementation of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo
The goal of this educational activity is to improve learners’ knowledge and competence in evidence-based use of JAK inhibitor therapies for patients with alopecia areata, atopic dermatitis, and vitiligo.

 

Target Audience
This activity is intended for dermatology nurse practitioners, physician associates and other advanced practice providers practicing in a dermatology setting.

 

Learning Objectives
Upon completion of this event, participants should be able to:

Closing Practice Gaps in Systemic Mastocytosis: A Skills-Based Intensive for APPs

  • Explain the underlying biology and disease heterogeneity of systemic mastocytosis, including key pathogenic mechanisms, clinical phenotypes, and conditions that commonly mimic SM in practice
  • Apply current consensus diagnostic frameworks—including clinical, laboratory, and pathologic criteria—to accurately identify systemic mastocytosis and determine disease subtype
  • Critically appraise emerging clinical evidence on targeted and disease-modifying therapies for systemic mastocytosis to support appropriate treatment selection and sequencing
  • Develop individualized, patient-centered management strategies that integrate shared decision-making, symptom burden, comorbidities, and multidisciplinary care coordination for patients with SM

Think You Know JAK? Essential Evidence to Aid Your Clinical Implementation of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo

  • Incorporate long-term safety and efficacy data for JAK inhibitors into treatment strategies for patients with atopic dermatitis
  • Evaluate recent clinical evidence for current and emerging JAK inhibitors in alopecia areata
  • Identify patients with vitiligo most likely to benefit from JAK inhibitor therapies based on emerging clinical trial evidence
  • Determine the role of JAK-STAT signaling in the pathophysiology of AA, AD, and vitiligo
  • Develop appropriate monitoring plans for patients with AA, AD, and vitiligo receiving JAK inhibitor therapy
  • Educate patients about the potential risks and benefits of JAK inhibitor therapies in AA, AD, and vitiligo.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 4.0 contact hours, including 4.0 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

A logo for a credit companyAI-generated content may be incorrect.

This activity was planned by and for the healthcare team, and learners will receive 4.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Closing Practice Gaps in Systemic Mastocytosis: A Skills-Based Intensive for APPs
Supported by an educational grant from Blueprint Medicines Corporation.

Think You Know JAK? Essential Evidence to Aid Your Clinical Implementation of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo
Supported by an independent educational grant from AbbVie.

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Clinical Care Options, LLC dba Decera Clinical Education

Supporter

Blueprint Medicines Corporation

AbbVie

Contact Information

For customer support please click here.

Mailing Address:

 

Decera Clinical
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.